Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GDUFA III: US FDA Says Generic Drug Supplement Volume Could Require More Resources
03 Feb 2021
•
By
Derrick Gingery
Will the growing workload cause GDUFA fees to increase or prompt other changes?
Controlled correspondence submissions also continue to increase and many relate to complex products. • Source: Shutterstock
More from Generics
More from Biosimilars & Generics